Your browser doesn't support javascript.
loading
Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming.
Villalba, Adrian; Rodriguez-Fernandez, Silvia; Perna-Barrull, David; Ampudia, Rosa-Maria; Gomez-Muñoz, Laia; Pujol-Autonell, Irma; Aguilera, Eva; Coma, Mireia; Cano-Sarabia, Mary; Vázquez, Federico; Verdaguer, Joan; Vives-Pi, Marta.
Afiliação
  • Villalba A; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.
  • Rodriguez-Fernandez S; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.
  • Perna-Barrull D; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.
  • Ampudia RM; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.
  • Gomez-Muñoz L; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.
  • Pujol-Autonell I; Immunology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.
  • Aguilera E; Endocrinology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.
  • Coma M; Anaxomics Biotech SL, Barcelona, Spain.
  • Cano-Sarabia M; Catalan Institute of Nanoscience and Nanotechnology, CSIC and The Barcelona Institute of Science and Technology, Bellaterra, Spain.
  • Vázquez F; Endocrinology Section, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.
  • Verdaguer J; Immunology Unit, Department of Experimental Medicine, Faculty of Medicine, IRBLleida, University of Lleida, Lleida, Spain.
  • Vives-Pi M; CIBER of Diabetes and Associated Metabolic Disease (CIBERDEM), ISCIII, Madrid, Spain.
Article em En | MEDLINE | ID: mdl-32477262

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 1 / Células Secretoras de Insulina / Peptídeo 1 Semelhante ao Glucagon / Reprogramação Celular / Liraglutida / Hiperglicemia Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 1 / Células Secretoras de Insulina / Peptídeo 1 Semelhante ao Glucagon / Reprogramação Celular / Liraglutida / Hiperglicemia Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha